HOME >> MEDICINE >> NEWS
Understanding genetic cancer risk might not help smokers kick the habit

DURHAM, N.C. -- If smokers knew that they were genetically susceptible to smoking-related cancers, would this knowledge help them stop smoking? New research from Duke University Medical Center shows that in an older, inner-city African-American population the answer is mixed. Smokers who knew they were genetically susceptible to smoking-related cancers were no more likely to quit smoking than those who found out they were not susceptible.

However, this lack of responsiveness to knowledge of genetic susceptibility is not completely a bad thing, said Colleen McBride, Ph.D., study leader and director of the Cancer Prevention, Detection and Control Program at Duke Comprehensive Cancer Center.

"We were concerned that telling smokers that they were not genetically susceptible might undermine their motivation to quit smoking and that was not the case. Unfortunately, being susceptible wasn't strong enough to motivate them to quit either," McBride said.

The study published in the July 2002 issue of Cancer Epidemiology, Biomarkers and Prevention examined 557 African-American smokers with low incomes from an inner-city community health clinic.

"We chose this group to test our intervention because quit rates are lowest among those with a low income," said McBride. "And, African-Americans bear a much greater health burden of smoking than whites. We know that many smokers quit because they are afraid of the health risks. We thought if we personalized that risk for people in our study, that it might convince them to quit smoking."

The researchers randomized the smokers into two groups. The first group of 185 participants received counseling about smoking cessation, a self-help smoking cessation guide and nicotine replacement therapy as appropriate. The second group of 372, received the counseling, guide and nicotine replacement therapy, but also agreed to take a blood test for a gene (GSTM1) that is linked to increased risk for lung cancer
'"/>

Contact: Amy Austell
amy.austell@duke.edu
919-684-4148
Duke University Medical Center
5-Jul-2002


Page: 1 2 3

Related medicine news :

1. Understanding how vulnerabilities may keep women in abusive relationships
2. From town planning to intimate sex: Understanding the risks in our lives
3. Understanding how prostaglandin prevents gut injury during radiation therapy
4. Understanding epilepsy
5. The long view: Understanding why cancer strikes late
6. Understanding the autoimmune response in type 1 diabetes
7. Understanding nerve degeneration in spastic paraplegia
8. Understanding how lymph nodes respond to infection may redefine how immune system functions
9. Understanding Alzheimers disease: Animal research points to new direction for therapy
10. Understanding cancer patients needs, concerns, is key to improving clinical trial participation
11. Understanding Why Antibiotics May Be Over-prescribed For Patients With Sore Throats

Post Your Comments:
(Date:5/24/2013)... 2013 The Dictation Source recently added ... clients. As a result of its National marketing efforts, ... 20 states around the nation. , Since 1991, The ... to the healthcare industry . Dictation Source is owned ... years of clinical work experience to provide the solutions ...
(Date:5/24/2013)... May 24, 2013 Based in ... a leading nationwide sales, installation and service provider ... and commercial applications. The company’s core products include ... lifts for mobility devices, pool lifts, turning automotive ... operates over 30 locations, primarily through its franchise ...
(Date:5/24/2013)... in five parents think they have little control over ... drug use, a new U.S. government survey finds. ... and Mental Health Services Administration (SAMHSA), since new research ... influential forces helping to shape their child,s views on ... that parents can make an enormous difference in influencing ...
(Date:5/24/2013)... The SunglassFIX Photo Contest lets ... while learning how to make their sunglasses, and ... only need to upload pictures of themselves, friends ... Sunglass Fix on Facebook in order to enter. ... lens replacement online store . , ...
(Date:5/24/2013)... A new investigational device - the Helio System (TF-FA) ... Transcatheter Heart Valve was successfully deployed in all four ... use in high-risk aortic insufficiency reported at EuroPCR 2013. ... to help stabilise the SAPIEN XT valve for patients ... are captured between the transcatheter heart valve and the ...
Breaking Medicine News(10 mins):Health News:The Dictation Source Signs Two National Hospital Chains 2Health News:The Dictation Source Signs Two National Hospital Chains 3Health News:Cortec Closes Equity Transaction with 101 Mobility 2Health News:Parents Underestimate Influence Over Teens' Substance Abuse: Survey 2Health News:Break the Sunglass Mold – Reuse 'Em, Don’t Toss 'Em then Enter the SunglassFIX Photo Contest to Win 2Health News:Feasibility trial reports deployment of new device for TAVI in aortic insufficiency 2
(Date:5/24/2013)... , May 24, 2013 China Biologic ... a leading fully integrated plasma-based biopharmaceutical company in ... has recently learned from a public announcement issued by ... public company listed on Shenzhen Stock Exchange, that on ... ("Ms. Chan"), one of the shareholders of ...
(Date:5/24/2013)... , May 24, 2013 In accordance with ... and Rule 14e-1 of the United States Exchange Act, Echo ... original offer for Elan Corporation (NYSE: ELN). Background ... ("Royalty Pharma") made an offer for the entire of the ... plc ("Elan") (the "Original Offer").  On 20 ...
(Date:5/24/2013)... LONDON , May 24, 2013 ... non-invasive administration for systemic delivery of therapeutic agents has ... the inhalation drug delivery showing significant promise. The crucial ... of a delivery device play a major role in ... been made in the development of new formulation techniques ...
Breaking Medicine Technology:China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2
Cached News: